Lawrence F. Eichenfield, MD - Rady Children's Hospital
Lawrence F. Eichenfield, MD - Rady Children's Hospital
Lawrence F. Eichenfield, MD - Rady Children's Hospital
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Curriculum VitaeAugust 2012<strong>Lawrence</strong> F. <strong>Eichenfield</strong>, M.D.132. Breneman D, Fleischer AB Jr, Abramovits W, Zeichner J, Gold MH, Kirsner RS, Shull TF,Crowe AW, Jaracz E, Hanifin JM: Tacrolimus ointment study group. Intermittent therapy forflare prevention and long-term disease control in stabilized atopic dermatitis: a randomizedcomparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. Journal ofAmerican Academy of Dermatology. 2008 Jun;58(6):990-999. Epub 2008 Mar21.133. Krakowski AC, Stendardo S, <strong>Eichenfield</strong> LF. Practical considerations in acne treatment and theclinical impact of topical combination therapy. Pediatric Dermatology 2008 Jun;25(Suppl 1):1-14.134. Jacob SE, Zapolanski T, Chayavichitsilp P, Connelly EA, <strong>Eichenfield</strong> LF. p-Phenylenediaminein black henna tattoos: a practice in need of policy in children. Archives of PediatricAdolescent Medicine. 2008 Aug;162(8):790-792.135. Krakowski AC, <strong>Eichenfield</strong> LF, Dohil MA. State-of-the-art review article: Management ofAtopic Dermatitis in the Pediatric Population. Pediatrics 2008 Oct;122(4):812-824.136. Paller AS, <strong>Eichenfield</strong> LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US tacrolimus ointmentstudy group. Three times weekly tacrolimus ointment reduces relapse in stabilized atopicdermatitis: a new paradigm for use. Pediatrics. 2008 Dec; 122(6): e1210-e1218. Epub 2008Nov 17.137. Yan AC, Frieden IJ, <strong>Eichenfield</strong> LF. Pediatric Dermatology. Announcing a new section.Pediatric Dermatology. 2008 Nov-Dec; 25(6):585-586.138. <strong>Eichenfield</strong> LF, Nighland M, Rossi AB, Cook-Bolden F, Grimes P, Fried R, Levy S, PUMPStudy Group. Phase 4 study to assess tretinoin pump for the treatment of facial acne. Journal ofDrugs in Dermatology. 2008 Dec; 7(12):1129-1136.139. Mayer JA, Slymen DJ, Clapp EJ, Pichon LC, Elder JP, Sallis JF, <strong>Eichenfield</strong> LF, WeinstockMA. Long-term maintenance of a successful occupational sun safety intervention. Archives ofDermatology. 2009 Jan;145(1):88-89.140. Chiang C, <strong>Eichenfield</strong> LF. Quantitative assessment of combination bathing and moisturizingregimens on skin hydration in atopic dermatitis. Pediatric Dermatology. 2009May/Jun;26(3):273-278.141. <strong>Eichenfield</strong> LF, Wortzman M. A novel gel formulation of 0.25% tretinoin and 1.2%clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years. PediatricDermatology. 2009 May/Jun;26(3):257-261.142. Dohil MA, Alvarez-Connelly E, <strong>Eichenfield</strong> LF. Fluocinolone acetonide 0.01% in peanut oil:safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3months of age. Pediatric Dermatology. 2009 May/Jun;26(3):262-268.------------------------143. Thiboutot D, <strong>Eichenfield</strong> L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E, Tschen E, ParrL. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoylperoxide. Cutis. 2009 Jul;84(1):48-55.Page 22 of 69